Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q4 2025 Earnings

12NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-7.34

-5.04

-2.75

-0.46

Details

Expected EPS

-0.612

Actual EPS

-0.64

Surprise EPS

-0.03

Surprise Percent

+4.58%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -0.64 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.